How does Immune-Frame work?
Serving as a follow-up tool, this test assesses the status of your immune system by identifying key cellular markers that regulate immune response.
Unlock personalized cancer care. Book a Test Now
Immune-Frame
The human immune system is the ‚police‘ that removes cancer as well as pathogens from the human body. Individuals who have cancer have a suppressed immune system especially when they undergo chemotherapy. The Immune-Frame would provide insights into the current state of a person’s immune system. These precision insights of the immune status would guide the selection or exclusion of therapies; that would better suit a given situation in relation to the ability of the human body to clear out the tumor cells.
Serving as a follow-up tool, this test assesses the status of your immune system by identifying key cellular markers that regulate immune response.
The Immune-Frame test provides essential insights to guide treatment planning and determine the most appropriate therapy for patients by examining various aspects of the immune system, including:
Presence and stimulation of dendritic cells (DCs)
Specific humoral and cellular Immunity
Non-specific cellular immunity
Immunosuppressive mechanisms
Activation of T and B memory cells for long-term immunity
Reserve your 30-minute free consultation
Immune-Frame delivers an in-depth assessment of a patient's immune system's condition and status.
The test analyzes blood samples to detect cytokines produced by specific cells.
With the identification of blood-borne markers, it helps determine the eligibility of cancer patients for immunotherapies.
Oncotrail has undergone rigorous evaluation to ensure high sensitivity and specificity, making it an invaluable tool for diagnostic purposes.
Through high-precision techniques, the test is used to monitor the effectiveness of a particular cancer treatment. This would objectively provide information on how well the treatment is going.
The non-invasive tracking of the cancer status would notify a treating physician whether to adjust current management or stay the course. This would be important to know in almost real-time rather than to find out much later that a treatment doesn't apply to a particular person.
Whole peripheral blood sample
15-25ml of whole peripheral blood
10-12 days in the lab
21 days after sample collection
Applicable for all cancer types
To whom it is relevant: The test is relevant for patients who want to go for immunotherapy.
A patient-centric revolution in cancer testing and monitoring. We are devoted to providing personalized tests designed with each patient’s unique genetic profile in mind.
©2024 All Rights Reserved. Designed by Bee High Media.